SCHEMBL8855171

SCHEMBL8855171

CC(=O)N(Nc1cccc(F)c1)c1ccccc1C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.45
▸ DAPK3 O43293 2/20 0.44
▸ PRKD3 O94806 2/20 0.44
▸ PIM1 P11309 2/20 0.44
▸ CDK2 P24941 2/20 0.44
▸ FLT3 P36888 2/20 0.44
▸ CSNK1A1 P48729 2/20 0.44
▸ GSK3B P49841 2/20 0.44
▸ CDK9 P50750 2/20 0.44
▸ JAK3 P52333 2/20 0.44
▸ CDK5 Q00535 2/20 0.44
▸ MAP4K2 Q12851 2/20 0.44
▸ DYRK1A Q13627 2/20 0.44
▸ MELK Q14680 2/20 0.44
▸ HIPK2 Q9H2X6 2/20 0.44
▸ CLK4 Q9HAZ1 2/20 0.44
▸ STK17A Q9UEE5 2/20 0.44
▸ HPGD P15428 2/20 0.44
▸ CDC7 O00311 1/20 0.44
▸ CDK7 P50613 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8479733 0.87 ALDH1A1 (0.45) HPGDRAB9AKDM4EGAAALDH1A1
SCHEMBL8479485 0.86 ALDH1A1 (0.49) DAPK3PIM1CDK2FLT3GSK3B
SCHEMBL9093965 0.85 KEAP1 (0.41) HTTHPGDNPC1RAB9AGAA
SCHEMBL8485493 0.79 ALDH1A1 (0.44) HPGDNPC1RAB9AKDM4EGAA
SCHEMBL8608850 0.78 KDM4E (0.43) HTTHPGDNPC1RAB9AMAPK8
SCHEMBL8606406 0.77 LMNA (0.48) HTTHPGDNPC1RAB9AGAA
SCHEMBL9094525 0.74 KDM4E (0.46) HPGDNPC1RAB9AKDM4EGAA
SCHEMBL9094581 0.74 GRIK1 (0.48) HPGDNPC1RAB9AKDM4EGAA
SCHEMBL6823572 0.71 RAB9A (0.58) HTTHPGDNPC1RAB9AKDM4E
SCHEMBL2700103 0.71 HTT (0.71) HTTHPGDNPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5681958-A TREATMENT OF DIABETES SHAMAN PHARMACEUTICALS, INC. (US) 1997-10-28 — — US disclosed
WO-1996010015-A1 CRYPTOLEPINE ANALOGS WITH HYPOGLYCEMIC ACTIVITY SHAMAN PHARMACEUTICALS, INC. (US) 1996-04-04 — — WO disclosed
Send feedback